Shui Cao
Tianjin, 300060, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Randomized pilot study of camrelizumab with or without autologous cytokine-induced killer cells in refractory clear cell renal cell carcinoma.
Journal: Scientific reports
Published: October 06, 2025
Association of concomitant H1 antihistamine and immune checkpoint inhibitor therapy on survival outcome and safety in patients with advanced primary lung cancer: a cohort study.
Journal: Translational lung cancer research
Published: September 02, 2024
Vemurafenib for BRAF V600-mutant Erdheim-Chester disease presenting with bilateral orbital involvement.
Journal: Clinical case reports
Published: April 21, 2023
Response to gefitinib/crizotinib combination in a pulmonary sarcomatoid carcinoma patient harboring concurrent EGFR mutation and MET amplification.
Journal: Clinical case reports
Published: February 27, 2021
Efficiency of Cytokine-Induced Killer Cells in Combination with Chemotherapy for Triple-Negative Breast Cancer.
Journal: Journal of breast cancer
Published: December 27, 2017
Efficacy and Survival Analysis of Apatinib in Patients with Advanced Nonsquamous Non-small Cell Lung Cancer after Failure of First-line Treatment
Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer
Published: November 24, 2017
Primary malignant melanoma arising in an ovarian cystic teratoma.
Journal: Melanoma research
Published: October 11, 2017
Cytokine-Induced Killer Cells Modulates Resistance to Cisplatin in the A549/DDP Cell Line.
Journal: Journal of Cancer
Published: January 31, 2017
Shorter telomere length of T-cells in peripheral blood of patients with lung cancer.
Journal: OncoTargets and therapy
Published: May 27, 2016
Predictive value of K-ras and PIK3CA in non-small cell lung cancer patients treated with EGFR-TKIs: a systemic review and meta-analysis.
Journal: Cancer biology & medicine
Published: March 30, 2015
Last Updated: 09/26/2026